484 related articles for article (PubMed ID: 28233640)
1. Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas.
Parker Kerrigan BC; Shimizu Y; Andreeff M; Lang FF
Cytotherapy; 2017 Apr; 19(4):445-457. PubMed ID: 28233640
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL.
Kazimirsky G; Jiang W; Slavin S; Ziv-Av A; Brodie C
Stem Cell Res Ther; 2016 Oct; 7(1):149. PubMed ID: 27724977
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma.
Ahmed AU; Tyler MA; Thaci B; Alexiades NG; Han Y; Ulasov IV; Lesniak MS
Mol Pharm; 2011 Oct; 8(5):1559-72. PubMed ID: 21718006
[TBL] [Abstract][Full Text] [Related]
4. Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases.
Leoni V; Gatta V; Palladini A; Nicoletti G; Ranieri D; Dall'Ora M; Grosso V; Rossi M; Alviano F; Bonsi L; Nanni P; Lollini PL; Campadelli-Fiume G
Oncotarget; 2015 Oct; 6(33):34774-87. PubMed ID: 26430966
[TBL] [Abstract][Full Text] [Related]
5. The use of hypoxic cultured mesenchymal stem cell for oncolytic virus therapy.
Huang YF; Chen MJ; Wu MH; Hung SC
Cancer Gene Ther; 2013 May; 20(5):308-16. PubMed ID: 23618949
[TBL] [Abstract][Full Text] [Related]
6. Systemic administration of mesenchymal stem cells loaded with a novel oncolytic adenovirus carrying IL-24/endostatin enhances glioma therapy.
Zhang J; Chen H; Chen C; Liu H; He Y; Zhao J; Yang P; Mao Q; Xia H
Cancer Lett; 2021 Jul; 509():26-38. PubMed ID: 33819529
[TBL] [Abstract][Full Text] [Related]
7. A specific subpopulation of mesenchymal stromal cell carriers overrides melanoma resistance to an oncolytic adenovirus.
Bolontrade MF; Sganga L; Piaggio E; Viale DL; Sorrentino MA; Robinson A; Sevlever G; García MG; Mazzolini G; Podhajcer OL
Stem Cells Dev; 2012 Sep; 21(14):2689-702. PubMed ID: 22462538
[TBL] [Abstract][Full Text] [Related]
8. Delivery of improved oncolytic adenoviruses by mesenchymal stromal cells for elimination of tumorigenic pancreatic cancer cells.
Kaczorowski A; Hammer K; Liu L; Villhauer S; Nwaeburu C; Fan P; Zhao Z; Gladkich J; Groß W; Nettelbeck DM; Herr I
Oncotarget; 2016 Feb; 7(8):9046-59. PubMed ID: 26824985
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model.
Rincón E; Cejalvo T; Kanojia D; Alfranca A; Rodríguez-Milla MÁ; Gil Hoyos RA; Han Y; Zhang L; Alemany R; Lesniak MS; García-Castro J
Oncotarget; 2017 Jul; 8(28):45415-45431. PubMed ID: 28525366
[TBL] [Abstract][Full Text] [Related]
10. Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas.
Zhang Q; Xiang W; Yi DY; Xue BZ; Wen WW; Abdelmaksoud A; Xiong NX; Jiang XB; Zhao HY; Fu P
Stem Cell Res Ther; 2018 Aug; 9(1):228. PubMed ID: 30143053
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells loaded with Ad5-Ki67/IL-15 enhance oncolytic adenovirotherapy in experimental glioblastoma.
Wang P; Zhang J; Zhang Q; Liu F
Biomed Pharmacother; 2023 Jan; 157():114035. PubMed ID: 36434955
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy.
Mahasa KJ; de Pillis L; Ouifki R; Eladdadi A; Maini P; Yoon AR; Yun CO
Sci Rep; 2020 Jan; 10(1):425. PubMed ID: 31949228
[TBL] [Abstract][Full Text] [Related]
13. Influence of carrier cells on the clinical outcome of children with neuroblastoma treated with high dose of oncolytic adenovirus delivered in mesenchymal stem cells.
Melen GJ; Franco-Luzón L; Ruano D; González-Murillo Á; Alfranca A; Casco F; Lassaletta Á; Alonso M; Madero L; Alemany R; García-Castro J; Ramírez M
Cancer Lett; 2016 Feb; 371(2):161-70. PubMed ID: 26655276
[TBL] [Abstract][Full Text] [Related]
14. RE: stem cells loaded with multimechanistic oncolytic herpes simplex virus variants for brain tumor therapy.
Krause MN; Sancho-Martinez I; Izpisua Belmonte JC
J Natl Cancer Inst; 2015 Jan; 107(1):368. PubMed ID: 25473104
[No Abstract] [Full Text] [Related]
15. How to get from here to there: tracking down invasive glioma cells.
Fine HA
J Natl Cancer Inst; 2014 Jun; 106(6):dju120. PubMed ID: 24838836
[No Abstract] [Full Text] [Related]
16. Human mesenchymal stromal cells as cellular drug-delivery vectors for glioblastoma therapy: a good deal?
Clavreul A; Pourbaghi-Masouleh M; Roger E; Lautram N; Montero-Menei CN; Menei P
J Exp Clin Cancer Res; 2017 Sep; 36(1):135. PubMed ID: 28962658
[TBL] [Abstract][Full Text] [Related]
17. [Oncolytic viruses for therapy of malignant glioma].
Sosnovtceva AO; Grinenko NF; Lipatova AV; Chumakov PM; Chekhonin VP
Biomed Khim; 2016 May; 62(4):376-90. PubMed ID: 27562991
[TBL] [Abstract][Full Text] [Related]
18. Application of mesenchymal stem cells as a vehicle to deliver replication-competent adenovirus for treating malignant glioma.
Hai C; Jin YM; Jin WB; Han ZZ; Cui MN; Piao XZ; Shen XH; Zhang SN; Sun HH
Chin J Cancer; 2012 May; 31(5):233-40. PubMed ID: 22429494
[TBL] [Abstract][Full Text] [Related]
19. Stem cells loaded with multimechanistic oncolytic herpes simplex virus variants for brain tumor therapy.
Duebgen M; Martinez-Quintanilla J; Tamura K; Hingtgen S; Redjal N; Wakimoto H; Shah K
J Natl Cancer Inst; 2014 Jun; 106(6):dju090. PubMed ID: 24838834
[TBL] [Abstract][Full Text] [Related]
20. Engineered adenoviruses combine enhanced oncolysis with improved virus production by mesenchymal stromal carrier cells.
Hammer K; Kazcorowski A; Liu L; Behr M; Schemmer P; Herr I; Nettelbeck DM
Int J Cancer; 2015 Aug; 137(4):978-90. PubMed ID: 25604186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
